Published in Exp Brain Res on December 11, 2009
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. Neuroscience (2010) 0.95
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. Neurotox Res (2010) 0.87
Perinatal asphyxia: CNS development and deficits with delayed onset. Front Neurosci (2014) 0.85
Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? EPMA J (2011) 0.85
Environmental enrichment decreases asphyxia-induced neurobehavioral developmental delay in neonatal rats. Int J Mol Sci (2013) 0.82
Effect of Marine Collagen Peptides on Physiological and Neurobehavioral Development of Male Rats with Perinatal Asphyxia. Mar Drugs (2015) 0.78
Complexity of Compensatory Effects in Nrf1 Knockdown: Linking Undeveloped Anxiety-Like Behavior to Prevented Mitochondrial Dysfunction and Oxidative Stress. Cell Mol Neurobiol (2015) 0.76
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats. Front Neuroanat (2015) 0.76
Perinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1β and TNF-α overexpression, and apoptotic-like cell death in mesencephalon of neonatal rats: prevention by systemic neonatal nicotinamide administration. Neurotox Res (2015) 0.75
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res (1988) 7.29
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev (2002) 5.92
Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol (1982) 5.58
Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell (2002) 4.87
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A (2001) 4.36
Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci (1994) 3.97
Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res (1985) 3.52
Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci (1985) 2.60
Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of information. Hippocampus (2001) 2.41
Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci (1995) 2.35
Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev (1997) 2.32
Consequences of neonatal seizures in the rat: morphological and behavioral effects. Ann Neurol (1998) 2.29
Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci (2001) 2.13
Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry (2002) 2.08
Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci (2008) 1.88
Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: computational modeling and brain slice physiology. J Neurosci (1994) 1.81
The recurrent mossy fiber pathway of the epileptic brain. Neurochem Res (2003) 1.80
Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J Neurosci (1991) 1.78
Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol (2002) 1.61
Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke (2001) 1.59
Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory. Nat Neurosci (2002) 1.56
The place of the hippocampus in fear conditioning. Eur J Pharmacol (2003) 1.55
Possible functional consequences of synaptic reorganization in the dentate gyrus of kainate-treated rats. Neurosci Lett (1992) 1.54
Hypoxia-ischemia in the immature brain. J Exp Biol (2004) 1.52
Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci (2000) 1.49
Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci (2002) 1.49
Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci (2001) 1.41
Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res (1990) 1.30
Kainic acid-induced recurrent mossy fiber innervation of dentate gyrus inhibitory interneurons: possible anatomical substrate of granule cell hyper-inhibition in chronically epileptic rats. J Comp Neurol (2006) 1.27
Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. Exp Brain Res (2001) 1.27
BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol (2000) 1.24
Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med (2001) 1.24
Spatial long-term memory is related to mossy fiber synaptogenesis. J Neurosci (2001) 1.23
Resistance of the immature hippocampus to seizure-induced synaptic reorganization. Brain Res Dev Brain Res (1991) 1.21
Mossy fiber sprouting after recurrent seizures during early development in rats. J Comp Neurol (1999) 1.21
Electrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sprouting. J Neurophysiol (2003) 1.21
Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res (2005) 1.11
Swimming navigation and structural variations of the infrapyramidal mossy fibers in the hippocampus of the mouse. Hippocampus (1991) 1.08
Radial-maze performance and structural variation of the hippocampus in mice: a correlation with mossy fibre distribution. Brain Res (1987) 1.06
Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci (2006) 1.05
Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav (2002) 1.04
PI3K inhibition in neonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolic cytochrome c and apoptosis. Brain Res Mol Brain Res (2004) 1.02
Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res (1994) 1.02
Ongoing epileptiform activity in the post-ischemic hippocampus is associated with a permanent shift of the excitatory-inhibitory synaptic balance in CA3 pyramidal neurons. J Neurosci (2006) 1.01
Translamellar disinhibition in the rat hippocampal dentate gyrus after seizure-induced degeneration of vulnerable hilar neurons. J Neurosci (2004) 1.01
Anxiety and hippocampus volume in the rat. Neuropsychopharmacology (2006) 1.00
Dentate gyrus: alterations that occur with hippocampal injury. Neurotoxicology (2003) 0.98
Changes in open field behavior, spatial memory, and hippocampal parvalbumin immunoreactivity following enrichment in rats exposed to neonatal anoxia. Exp Neurol (1996) 0.96
Epilepsy and synaptic reorganization in a perinatal rat model of hypoxia-ischemia. Epilepsia (2004) 0.95
Hippocampal function required for nonspatial working memory. Exp Brain Res (1981) 0.95
Spatial learning induces presynaptic structural remodeling in the hippocampal mossy fiber system of two rat strains. Hippocampus (2006) 0.95
Encephalopathy as a predictor of magnetic resonance imaging abnormalities in asphyxiated newborns. Pediatr Neurol (2003) 0.94
Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res (1999) 0.92
Long-lasting behavioral alterations following a hypoxic/ischemic brain injury in neonatal rats. Brain Res (2000) 0.92
A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J Pharmacol Exp Ther (2004) 0.92
Neuropsychological long-term sequelae of perinatal asphyxia. Brain Inj (2001) 0.92
Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res (2002) 0.92
Neuropathogical features of a rat model for perinatal hypoxic-ischemic encephalopathy with associated epilepsy. J Comp Neurol (2007) 0.91
Plasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesis. J Neurosci Res (2008) 0.91
Seizure, neuron loss, and mossy fiber sprouting in herpes simplex virus type 1-infected organotypic hippocampal cultures. Epilepsia (2004) 0.91
Characterization of target cells for aberrant mossy fiber collaterals in the dentate gyrus of epileptic rat. Exp Neurol (1997) 0.90
Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav Brain Res (1991) 0.90
Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Res (1991) 0.90
Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Res Bull (2005) 0.90
A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther (2004) 0.89
Assessing the functional significance of mossy fiber sprouting. Epilepsy Res Suppl (1992) 0.89
Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat. Psychopharmacology (Berl) (1995) 0.89
Delayed neuronal death following perinatal asphyxia in rat. Exp Brain Res (1997) 0.88
Dissociation of spatial reference memory, spatial working memory, and hippocampal mossy fiber distribution in two rat strains differing in emotionality. Behav Brain Res (1997) 0.88
Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci Lett (2000) 0.88
Neonatal hypoxia triggers transient apoptosis followed by neurogenesis in the rat CA1 hippocampus. Pediatr Res (2004) 0.87
The NAD+ precursors, nicotinic acid and nicotinamide upregulate glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun (1999) 0.86
Learning-induced axonal remodeling: evolutionary divergence and conservation of two components of the mossy fiber system within Rodentia. Neurobiol Learn Mem (2006) 0.86
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem (2000) 0.85
Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J Neurochem (1995) 0.85
Effect of graded hypoxia on cerebral cortical genomic DNA fragmentation in newborn piglets. Biol Neonate (2001) 0.84
Hippocampal mossy fiber sprouting and elevated trkB receptor expression following systemic administration of low dose domoic acid during neonatal development. Hippocampus (2007) 0.84
Adrenalectomy regulates apoptotic-associated genes in rat hippocampus. Endocrine (2001) 0.84
Apoptosis and neurogenesis after transient hypoxia in the developing rat brain. Semin Perinatol (2004) 0.83
Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior. Semin Perinatol (2004) 0.83
The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharmacol Exp Ther (1996) 0.82
Long-term effect of moderate and profound hypothermia on morphology, neurological, cognitive and behavioural functions in a rat model of perinatal asphyxia. Amino Acids (2006) 0.82
Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat. Life Sci (1999) 0.82
C-section birth per se or followed by acute global asphyxia altered emotional behaviour in neonate and adult rats. Behav Brain Res (2005) 0.82
Plasticity of basal ganglia neurocircuitries following perinatal asphyxia: effect of nicotinamide. Exp Brain Res (2007) 0.81
Nicotinamide prevents the effect of perinatal asphyxia on dopamine release evaluated with in vivo microdialysis 3 months after birth. Exp Brain Res (2007) 0.80
Acute global anoxia during C-section birth affects dopamine-mediated behavioural responses and reactivity to stress. Behav Brain Res (2004) 0.80
Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth. Exp Neurol (1997) 0.80
Long term neurological and behavioral effects of graded perinatal asphyxia in the rat. Life Sci (2000) 0.80
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats. Exp Brain Res (2007) 0.80
D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res Bull (1999) 0.79
Effects of hypothermia and gender on survival and behavior after perinatal asphyxia in rats. Physiol Behav (2000) 0.78
Plasticity of the central nervous system (CNS) following perinatal asphyxia: does nicotinamide provide neuroprotection? Amino Acids (2006) 0.78
Nicotinamide prevents the long-term effects of perinatal asphyxia on basal ganglia monoamine systems in the rat. Exp Brain Res (2002) 0.78
Short- and long-term effects of perinatal asphyxia on monoamine, amino acid and glycolysis product levels measured in the basal ganglia of the rat. Brain Res Dev Brain Res (1997) 0.78
Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter systems studied with microdialysis in rat. Neurosci Lett (1994) 0.78
Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. Exp Brain Res (2001) 0.78
Changes in the structure of the rat hippocampus after prolonged postnatal hypoxia. Physiol Bohemoslov (1982) 0.77
Developmental status of neurons selectively vulnerable to rapidly triggered post-ischemic caspase activation. Neurosci Lett (2004) 0.77
Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci (2006) 2.14
Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res (2011) 1.79
PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci (2007) 1.62
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J (2002) 1.47
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression. Exp Neurol (2010) 1.44
Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata. Exp Neurol (2003) 1.38
Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke (2008) 1.31
Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia (2005) 1.22
Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care. EPMA J (2011) 1.17
The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res (2007) 1.09
New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists. Life Sci (2005) 1.02
Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem (2002) 0.99
Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J Neuroimmunol (2005) 0.99
Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neurochem (2009) 0.98
Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur J Neurosci (2002) 0.97
Ethanol induces stronger dopamine release in nucleus accumbens (shell) of alcohol-preferring (bibulous) than in alcohol-avoiding (abstainer) rats. Eur J Pharmacol (2008) 0.96
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward. Neuropharmacology (2012) 0.95
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. J Med Chem (2008) 0.93
Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. Eur J Pharmacol (2002) 0.92
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2012) 0.91
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. Brain (2012) 0.91
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study. Acta Neuropathol (2012) 0.90
EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. Brain Res (2003) 0.88
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. Neurotox Res (2010) 0.87
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties. Eur J Med Chem (2003) 0.87
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats. Synapse (2002) 0.87
Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry (2010) 0.85
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology (2009) 0.85
Reward and relapse: complete gene-induced dissociation in an animal model of alcohol dependence. Alcohol Clin Exp Res (2011) 0.85
Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? EPMA J (2011) 0.85
Involvement of Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE) and Rac1 in the phagocytosis of amyloid-beta(1-42) in rat microglia. J Pharmacol Sci (2003) 0.85
Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Neuropsychopharmacology (2004) 0.85
Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol (2004) 0.84
The "first hit" toward alcohol reinforcement: role of ethanol metabolites. Alcohol Clin Exp Res (2015) 0.84
Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol. Eur J Pharmacol (2007) 0.84
Selective reductions in subpopulations of GABAergic neurons in a developmental rat model of epilepsy. Brain Res (2010) 0.84
Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse (2001) 0.84
Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatments. NeuroRehabilitation (2012) 0.84
Hippocampal mossy fiber sprouting and elevated trkB receptor expression following systemic administration of low dose domoic acid during neonatal development. Hippocampus (2007) 0.84
Low-dose neonatal domoic acid causes persistent changes in behavioural and molecular indicators of stress response in rats. Behav Brain Res (2012) 0.83
The alcohol deprivation effect: marked inhibition by anticatalase gene administration into the ventral tegmental area in rats. Alcohol Clin Exp Res (2013) 0.83
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. Synapse (2008) 0.83
Systems biology in psychiatric research: from complex data sets over wiring diagrams to computer simulations. Methods Mol Biol (2012) 0.83
Low doses of non-NMDA glutamate receptor agonists alter neurobehavioural development in the rat. Neurotoxicol Teratol (2003) 0.83
Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. Synapse (2007) 0.83
Possible involvement of small oligomers of amyloid-beta peptides in 15-deoxy-delta 12,14 prostaglandin J2-sensitive microglial activation. J Pharmacol Sci (2003) 0.83
Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Gene specific modifications unravel ethanol and acetaldehyde actions. Front Behav Neurosci (2013) 0.82
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J Neural Transm (Vienna) (2014) 0.82
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. Exp Neurol (2013) 0.82
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats. Addict Biol (2013) 0.82
Perinatal exposure to alcohol disturbs spatial learning and glutamate transmission-related gene expression in the adult hippocampus. Eur J Neurosci (2011) 0.82
Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeine. Behav Brain Res (2006) 0.82
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease. Neurotox Res (2009) 0.82
Synthesis of new 2-arylamino-6-trifluoromethylpyridine-3-carboxylic acid derivatives and investigation of their analgesic activity. Bioorg Med Chem (2004) 0.82
Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain. Neurotox Res (2009) 0.81
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol (2007) 0.81
Plasticity of basal ganglia neurocircuitries following perinatal asphyxia: effect of nicotinamide. Exp Brain Res (2007) 0.81
Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy. EPMA J (2010) 0.81
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur J Pharmacol (2003) 0.81
Some aspects on the anatomy and function of central cholecystokinin systems. Pharmacol Toxicol (2002) 0.81
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease. Behav Pharmacol (2009) 0.81
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. J Neurochem (2014) 0.81
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats. Exp Brain Res (2007) 0.80
Nicotinamide prevents the effect of perinatal asphyxia on dopamine release evaluated with in vivo microdialysis 3 months after birth. Exp Brain Res (2007) 0.80
Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology (2003) 0.80
How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease? Behav Pharmacol (2006) 0.80
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists. Neurotox Res (2013) 0.80
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. Neurology (2003) 0.80
Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology (Berl) (2005) 0.80
Rat strain influences the use of egocentric learning strategies mediated by neostriatum. Exp Brain Res (2008) 0.80
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology (2010) 0.80
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons. J Neurochem (2006) 0.80
Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases. Neurotherapeutics (2009) 0.80
Intensive rehabilitation treatment in parkinsonian patients with dyskinesias: a preliminary study with 6-month followup. Parkinsons Dis (2012) 0.80